Xie, Bingru <br/><br/>
Sorafenib for treatment of hepatocellular carcinoma: a systematic review.  [electronic resource] 

 -  Digestive diseases and sciences  May 2012 
 - 1122-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-012-2136-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Protocols<br/>Benzenesulfonates--administration & dosage<br/>Carcinoma, Hepatocellular--complications<br/>Cell Proliferation--drug effects<br/>Chemoembolization, Therapeutic--methods<br/>Hand-Foot Syndrome<br/>Hepatitis, Viral, Human--complications<br/>Humans<br/>Liver--metabolism<br/>Liver Cirrhosis--complications<br/>Liver Neoplasms--complications<br/>Neovascularization, Pathologic--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyridines--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Receptor Protein-Tyrosine Kinases--metabolism<br/>Sorafenib<br/>Treatment Outcome<br/>raf Kinases--metabolism